Stephen Uden

CIK: 0001332141

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (66.7%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RLYB

Rallybio Corp

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

RLYB
Rallybio Corp
Oct 27, 2026
Exercise(M)
Direct
33.2K shares at avg. $6.08$202K
RLYB
Rallybio Corp
Oct 6, 2026
Exercise(M)
Direct
22.5K shares at avg. $6.08$137K
RLYB
Rallybio Corp
Feb 14, 2025
Award(A)
Option (Right to Buy)
Direct
453.7K shares-

		Type	Shares	Price		Ownership
Oct 27, 2026	RLYB Rallybio Corp	Exercise(M)	33,244	$6.08	$202,124	Direct
Oct 6, 2026	RLYB Rallybio Corp	Exercise(M)	22,456	$6.08	$136,532	Direct
Feb 14, 2025	RLYB Rallybio Corp	Award(A) Option (Right to Buy)	453,700	-	-	Direct

1-3 of 3 transactions

About Uden Stephen

Uden Stephen (SEC CIK 0001332141) files insider reports with the SEC as Chief Executive Officer of Rallybio Corp (RLYB).

Signal8 holds 3 ownership filings by Uden Stephen, all Form 4s, filed between Feb 19, 2025 and Oct 29, 2026. Those filings report 3 transactions, from Feb 14, 2025 to Oct 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Uden Stephen's filings is in EAST BERLIN, CT.

Recent filings by Uden Stephen

Oct 27, 2026: Option exercise of RLYB shares (Form 4, code M).
Oct 6, 2026: Option exercise of RLYB shares (Form 4, code M).
Feb 14, 2025: Grant or award of RLYB derivative securities (Form 4, code A).

Other insiders filing for Rallybio Corp (RLYB)

Lieber Jonathan I, Chief Financial Officer
HUNT RONALD, Director
Nash Christine A, Director
Chung Wendy, Director
Soteropoulos Paula, Director
Boudreau Helen M, Director

How to read Form 4 transaction codes